Pentoxi-Mepha 400, Retardtabletten

7680493240140 CH-49324 Tabletten
Pentoxi-Mepha 400, Retardtabletten
Pentoxi-Mepha 400, Retardtabletten
Pentoxi-Mepha 400, Retardtabletten
1 / 3
google

Article details

Package size
20
Selling units
20
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
14/04/2023
Patient information leaflet
Français
14/04/2023
Patient information leaflet
Italien
14/04/2023
Summary of Product Characteristics
Allemand
14/04/2023
Summary of Product Characteristics
Français
14/04/2023
Summary of Product Characteristics
Italien
14/04/2023

Detailed composition

Substance Quantity Type Category
(N/A)
400.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
49324
Drug name
Pentoxi-Mepha 400, Retardtabletten
Galenic form
RETT
ATC Code
C04AD03
Authorization status
Z
Dispensing category
B
First authorization
30/06/1988
Authorization expiration date
31/12/2025
IT Number
02.04.5.
Domain
Human medicine
Field of application
Durchblutungsstörungen

Package details

Description (FR)
PENTOXI Mepha cpr ret 400 mg 20 pce
Description (DE)
PENTOXI Mepha Ret Tabl 400 mg 20 Stk
Narcotic (BTM)
No

Other package sizes (1)

PENTOXI Mepha cpr ret 400 mg 100 pce
100 TABL
GTIN: 7680493240225
Not in V1